Results 211 to 220 of about 1,259,388 (355)

A multi-component prime-boost vaccination regimen with a consensus MOMP antigen enhances Chlamydia trachomatis clearance [PDF]

, 2016
Badamchi-Zadeh, A, Barinaga, G, Follman, F, Gomes, JP, Korber, BT, McKay, PF, Nunes, A, Shattock, RJ, Tregoning, JS, Walters, AA   +9 more
core   +1 more source

Characterization of rifampin-resistant <em>Staphylococcus aureus</em> nasal carriage in patients receiving rifampin-containing regimens for tuberculosis

, 2018
Yu‐Tsung Huang, Chun‐Hsing Liao, Shey‐Ying Chen, Chia‐Jui Yang, Hsin-Sui Hsu, Lee‐Jene Teng, Po‐Ren Hsueh   +6 more
openalex   +2 more sources

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia [PDF]

, 2006
Partow Kebriaei, Rima M. Saliba, Carrie Ma, Cindy Ippoliti, Daniel R. Couriel, Marcos de Lima, Sergio Giralt, Muzaffar H. Qazilbash, James Gajewski, Chul S. Ha, Richard E. Champlin, Issa F. Khouri   +11 more
openalex   +1 more source

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh, Dalia Sriwi, Callie Saric, Tripti Singh, Christie M. Bartels, Shivani Garg   +5 more
wiley   +1 more source

Immune profile analysis of head and neck squamous cell carcinoma before and after neoadjuvant treatment with the IRX-2 regimen [PDF]

, 2017
Gregory T. Wolf, Jason G. Newman, Neil L. Berinstein, Michael J. McNamara, Ariane Nguyen, James E. Egan, Michael J. Kaplan   +6 more
openalex   +1 more source

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel, Fauzia Hollangel, Caroline Packee, Amita Kapoor, Brad Rovin, Nathalie Costedoat‐Chalumeau, Shivani Garg   +6 more
wiley   +1 more source

Pharmacogenetic Associations with Statin Regimen Modification, Intolerance, and Adverse Outcomes in Coronary Artery Disease Patients. [PDF]

Pharmaceuticals (Basel)
Abdel-Latif R, Mohammed S, Saad M, Kunji K, Al-Muftah W, El-Menyar A, Al Suwaidi J.   +6 more
europepmc   +1 more source

Clinical, histological, and serological predictors of renal function loss in lupus nephritis.

Arthritis Care &Research, Accepted Article.
Objective Kidney survival is the ultimate goal in lupus nephritis (LN) management, but long‐term predictors remain inadequately studied, requiring long‐term follow‐up. This study aimed to identify baseline and early longitudinal predictors of kidney survival in the Accelerating Medicines Partnership LN longitudinal cohort.
Shangzhu Zhang, Laurence Magder, Daniel Goldman, Judith A. James, Joel M Guthridge, Carla Guthridge, Peter Izmirly, Jill P Buyon, H.Michael Belmont, Richard A. Furie, Noa Schwartz, Chaim Putterman, Jennifer L. Barnas, Jennifer H. Anolik, Sarah French, Maria Dall'era, Avi Z. Rosenberg, Jeffrey Hodgin, Dawit S. Demeke, the Accelerating Medicines Partnership RA/SLE Network, Michelle Petri, Andrea Fava   +21 more
wiley   +1 more source

Evaluating treatment outcomes stratified by regimen among drug-resistant TB patients in Sierra Leone. [PDF]

Public Health Action
Koroma JA, Fofanah BD, Nair D, Kamau EM, Kamara IF, Sesay MA, Turay IS, Sesay N, Kanu F, Lahai WK, Kanu JS, Koroma AT, Fornah F, Seisay AL, Bailor SS, Harding R, Emezue S, Tefera GB, Ameh G, Mazzi M, Lakoh S, Mahmoud M.   +21 more
europepmc   +1 more source

Effect Of Inpatient Admissions On Treatment Regimens In Patients With Type 2 Diabetes [PDF]

, 2014
JJ Ellis, Jonathan Bouchard, Vishal Saundankar, Jean C. Baltz, Yunus Meah, Chad Moretz   +5 more
openalex   +1 more source